Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Cary Moxham"'
Autor:
Christian Trepo, M. R. Blum, Herve Mommeja-Marin, Cary Moxham, Seng Gee Lim, Patrick Marcellin, F. Rousseau, Andrea Snow, Hie-Won Hann, Nancy Leung, George K. K. Lau, Jeff Sorbel
Publikováno v:
Alimentary Pharmacology & Therapeutics. 27:1282-1292
Summary Background Clevudine is a polymerase inhibitor that has the unusual feature of delayed viral rebound after therapy in some patients which may be related to its pharmacokinetics. Aim To characterize pharmacokinetic and pharmacodynamic profile
Autor:
Franck S, Rousseau, Charles, Wakeford, Herve, Mommeja-Marin, Ian, Sanne, Cary, Moxham, Jeanette, Harris, Laura, Hulett, Laurene H, Wang, Joseph B, Quinn, David W, Barry
Publikováno v:
The Journal of Infectious Diseases. 188:1652-1658
We conducted a randomized, open-label, 10-day study that compared the antiretroviral activity of emtricitabine (FTC) 25, 100, and 200 mg once daily and lamivudine (3TC) 150 mg 2 times/day in 82 human immunodeficiency virus (HIV)-infected patients wit
Publikováno v:
AIDS. 15:1369-1377
AIM To estimate the effectiveness of triple combination therapy in antiretroviral-naive adults. METHODS A systematic overview of results from clinical trials involving triple combination therapy with dual nucleoside reverse transcriptase inhibitors (
Autor:
Nathalie Adda, Joseph J. Eron, Jeffrey M. Jacobson, Jian Zong, Cary Moxham, Melanie A. Thompson, Gong Shen, Franck Rousseau, Harold A. Kessler, Jeanette Harris
Publikováno v:
AIDS (London, England). 19(15)
Objectives: To evaluate the pharmacodynamics and safety of escalating doses of amdoxovir (DAPD) monotherapy administered to treatment-naive and experienced HIV-1 -infected patients over 15 days. Design: Ninety patients with plasma HIV-1 RNA levels be
Autor:
M. Yamamoto, J.-P. Sommadossi, George M. Szczech, Cary Moxham, R. Endoh, Phillip A. Furman, G. R. Painter, M. R. Blum, Katyna Borroto-Esoda, T. B. Grizzle, T. Niwa, David W. Barry
Emivirine (EMV), formerly known as MKC-442, is 6-benzyl-1-(ethoxymethyl)-5-isopropyl-uracil, a novel nonnucleoside reverse transcriptase inhibitor that displays potent and selective anti-human immunodeficiency virus type 1 (HIV-1) activity in vivo. E
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85b6fba2b3d97194e520bd07c65c7f03
https://europepmc.org/articles/PMC89637/
https://europepmc.org/articles/PMC89637/